SCHEMBL27614756

SCHEMBL27614756

O=S(=O)(O)c1cnns1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27534342 0.76
SCHEMBL7082340 0.73 MAPT (0.39)
SCHEMBL27515442 0.67
SCHEMBL2405352 0.62
SCHEMBL7262093 0.62
Fluoride SCHEMBL27814813 0.60 HDAC8 (0.36)
SCHEMBL1348269 0.60 KDM4E (0.32)
Hydrochloric Acid SCHEMBL27576989 0.60 HDAC8 (0.36)
SCHEMBL7040277 0.60
SCHEMBL1416134 0.60 L3MBTL1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101668757-A Pyrrolo [2, 3-b] pyridine derivatives as kinase modulators PLEXXIKON INC 2010-03-10 CN claimed
CN-1665802-A Bisarylsulfonamide compounds and their use in cancer therapy CYCLACEL LTD (GB) 2005-09-07 CN claimed
CN-101878219-A Imidazothiadiazoles for use as protein kinase inhibitors CT NAC DE INVESTIGACIONES ONCO 2010-11-03 CN disclosed
CN-101668757-A Pyrrolo [2, 3-b] pyridine derivatives as kinase modulators PLEXXIKON INC 2010-03-10 CN disclosed
CN-1665802-A Bisarylsulfonamide compounds and their use in cancer therapy CYCLACEL LTD (GB) 2005-09-07 CN disclosed